Our COVID-19 Response:
Visit the InvisiMask™ Information page to learn about the InvisiMask nasal spray, our investigational daily human antibody nasal spray to provide active protection against COVID-19.
Harnessing the evolutionary power of the immune system with the goal of curing cancer
Focusing on developing safe and effective T-cell therapies with the potential to be widely accessible to cancer patients
Two proprietary platforms:
ArtemiS®
Utilizing the natural biology of T-cells to fight cancer
E-Alpha®
Leveraging antibody discovery platform to develop highly specific antibodies
A robust pipeline that encompasses T-cell therapies targeting a variety of tumor antigens
